| scholarly article | Q13442814 |
| P2093 | author name string | Michael J Mihatsch | |
| Lukas Bubendorf | |||
| Michael Dickenmann | |||
| Jürg Steiger | |||
| Spasenija Savic | |||
| Olivier Prince | |||
| P2860 | cites work | New human papovavirus (B.K.) isolated from urine after renal transplantation | Q28236639 |
| BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game | Q33848752 | ||
| Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. | Q33861021 | ||
| Polyomaviruria in renal transplant patients is not correlated to the cold ischemia period or to rejection episodes. | Q33974937 | ||
| Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy | Q34201921 | ||
| BK virus infection in a kidney allograft diagnosed by needle biopsy | Q34296589 | ||
| Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation | Q34719108 | ||
| Human polyoma virus (HPV)--a significant pathogen in renal transplantation | Q40206077 | ||
| Human polyoma virus infection of renal allografts: histopathologic diagnosis, clinical significance, and literature review | Q41002876 | ||
| Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature | Q41477413 | ||
| BK virus infection in kidney transplant recipients | Q42169525 | ||
| Cost efficiency in the prospective diagnosis and follow-up of polyomavirus allograft nephropathy | Q43530174 | ||
| Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring | Q43536824 | ||
| A prospective longitudinal study of BK virus infection in 104 renal transplant recipients | Q43603996 | ||
| Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis | Q43605141 | ||
| Polyomavirus (BK) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis | Q43738683 | ||
| Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy | Q43782396 | ||
| Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy | Q43800287 | ||
| Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents | Q43975352 | ||
| Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology | Q44051167 | ||
| Clinical course of polyoma virus nephropathy in 67 renal transplant patients | Q44077395 | ||
| Urological manifestations of BK polyomavirus in renal transplant recipients. | Q44099247 | ||
| Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients | Q44104230 | ||
| Immunosuppression and BKV Nephropathy | Q44255077 | ||
| Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults | Q44289414 | ||
| Treatment of refractory BK virus-associated nephropathy with cidofovir | Q44339748 | ||
| Graft dysfunction and polyomavirus infection in renal allograft recipients | Q44365660 | ||
| BK polyoma virus nephropathy in kidney transplant recipient: the role of new immunosuppressive agents | Q44366716 | ||
| Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches | Q44419275 | ||
| Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs | Q44441935 | ||
| Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy | Q44503856 | ||
| Infection with polyomavirus type BK after renal transplantation | Q44563055 | ||
| BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis | Q44571746 | ||
| BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. | Q44583038 | ||
| Polyomavirus BK infection. | Q44608610 | ||
| The high incidence of BK polyoma virus infection among renal transplant recipients in India. | Q44765906 | ||
| Improved outcome of polyoma virus allograft nephropathy with early biopsy | Q44863789 | ||
| The use of vidarabine in the treatment of human polyomavirus associated acute haemorrhagic cystitis | Q44924436 | ||
| Risk factors for BK polyomavirus nephritis in renal allograft recipients | Q44963405 | ||
| HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients | Q45058863 | ||
| BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression | Q45103464 | ||
| Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load | Q45171040 | ||
| Polyomavirus nephropathy in pediatric kidney transplant recipients | Q45171047 | ||
| Prevalence, characteristics, and outcome of BK virus nephropathy in Japanese renal transplant patients: analysis in protocol and episode biopsies | Q45230214 | ||
| Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction | Q45262232 | ||
| Polyomavirus nephropathy in native kidneys of non-renal transplant recipients | Q45262237 | ||
| Prospective evaluation of BK virus DNAemia in renal transplant patients and their transplant outcome | Q45407573 | ||
| BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. | Q45423862 | ||
| Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia | Q45427404 | ||
| BK virus infection in renal allograft recipients | Q45729112 | ||
| BK virus and SV40 co-infection in polyomavirus nephropathy | Q45729817 | ||
| Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine | Q45730363 | ||
| Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients | Q45737444 | ||
| Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology | Q45747743 | ||
| Human polyoma virus-associated interstitial nephritis in the allograft kidney | Q45751593 | ||
| Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients. | Q45953243 | ||
| Polyomavirus nephropathy after renal transplantation: a single centre experience | Q46475721 | ||
| Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. | Q51477157 | ||
| Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender. | Q51757878 | ||
| BK polyomavirus interstitial nephritis in a renal allograft recipient. | Q53659517 | ||
| Quantitation of DNA of polyomaviruses BK and JC in human kidneys. | Q53667951 | ||
| BK viral infection in an Australian pediatric renal transplant population. | Q54701671 | ||
| Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children | Q64381774 | ||
| Tubulo-Interstitial Nephritis Associated with Polyomavirus (BK Type) Infection | Q67287983 | ||
| Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants | Q70142893 | ||
| Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients | Q73207712 | ||
| Polyomavirus infection and acute vascular rejection in a kidney allograft: coincidence or mimicry? | Q73267392 | ||
| Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients | Q73337924 | ||
| Polyomavirus in kidney and kidney-pancreas transplant recipients | Q73489197 | ||
| Nephropathy due to polyomavirus type BK | Q73740281 | ||
| Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients | Q74138259 | ||
| Risk factors for severe hemorrhagic cystitis following BMT | Q74484136 | ||
| Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss | Q77312467 | ||
| Polyomavirus DNA and RNA detection in renal allograft biopsies: results from a European multicenter study | Q81246889 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 1024-1033 | |
| P577 | publication date | 2008-12-10 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Risk factors for polyoma virus nephropathy | |
| P478 | volume | 24 |
| Q47673367 | Absence of JC polyomavirus (JCPyV) viremia in early post-transplant JCPyV nephropathy: A case report |
| Q42673998 | Assessment of Efficacy and Safety of FK778 in Comparison With Standard Care in Renal Transplant Recipients With Untreated BK Nephropathy |
| Q42261773 | Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor |
| Q38570451 | BK Virus Nephropathy in Kidney Transplantation: An Approach Proposal and Update on Risk Factors, Diagnosis, and Treatment |
| Q98612877 | BK Virus Nephropathy: Prevalence, Impact and Management Strategies |
| Q35099077 | BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression |
| Q42272314 | BK polyomavirus in solid organ transplantation |
| Q45354262 | BK virus viremia in a well-HLA-matched kidney transplant population mainly on low-dose cyclosporine-based immunosuppression |
| Q38155288 | Clinical courses of renal transplant recipients with high BK viremia |
| Q40584647 | Correlation between the presence of degenerated inclusion-bearing cells in voided urine samples and the occurrence of polyomavirus infection |
| Q43222628 | Cyclosporine versus tacrolimus in immunosuppressive maintenance regimens in renal transplants in Brazil: survival analysis from 2000 to 2004. |
| Q35281597 | Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil |
| Q41019245 | De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation |
| Q38061056 | Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms |
| Q44743039 | Genotypic diversity of polyomaviruses circulating among kidney transplant recipients in Kuwait |
| Q35401835 | Haematuria in postrenal transplant patients |
| Q37762535 | Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update |
| Q38930188 | Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy |
| Q36126901 | Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients |
| Q40537031 | Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy. |
| Q61799145 | Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation |
| Q41087673 | JC polyomavirus nephropathy confirmed by using an in-house polymerase chain reaction method. |
| Q38003050 | Management of polyomavirus-associated nephropathy in renal transplant recipients |
| Q38558078 | Opportunistic infections complicating solid organ transplantation with alemtuzumab induction |
| Q38006194 | Other viral infections in solid organ transplantation |
| Q37155134 | Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences |
| Q40659387 | Prevalence of polyoma BK virus infection among living-donor renal transplant recipients |
| Q99605702 | Renal Allograft Biopsies with Polyomavirus BK Nephropathy: Turin Transplant Center, 2015-19 |
| Q40929519 | Risk Factors for the Development of BK Virus Nephropathy in Renal Transplant Recipients |
| Q41604365 | Risk factors for BK virus infection and BK virus-associated nephropathy under the impact of intensive monitoring and pre-emptive immunosuppression reduction |
| Q51873726 | Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids. |
| Q39759053 | Screening for latent BK virus infection in a renal transplant population for the first time in Romania: a single-center experience |
| Q38750337 | Sex differences in transplantation |
| Q54590640 | Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. |
| Q42276202 | Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients |
| Q62588845 | The Status of BK Polyomavirus Replication in Adult Renal Transplant Recipients in Northeastern Poland |
| Q45366112 | The case of BK virus infection in which it was difficult to differentiate from acute rejection |
| Q37937222 | The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen. |
| Q42143824 | Urinary decoy cell grading and its clinical implications |
Search more.